Stay up to date with notifications from The Independent

Notifications can be managed in browser preferences.

Coronavirus: Intensive care survival rates have risen, study shows

'As the pandemic progresses, we may be coping better with Covid-19,' researchers say

Ella Pickover
Thursday 16 July 2020 09:32 EDT
Comments
In the UK, one in five people admitted to ICU stayed for over four weeks
In the UK, one in five people admitted to ICU stayed for over four weeks (AP)

Your support helps us to tell the story

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.

At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.

The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.

Your support makes all the difference.

The sickest Covid-19 patients are now more likely to survive a stint in intensive care, a new study suggests.

Experts, led by researchers in Bath, said that a fall in the death rate may suggest that “we are coping better with Covid-19”.

The new study, published in the journal Anaesthesia, examined a range of studies across three continents.

Across Europe, Asia and North America the death rate for intensive care unit (ICU) patients fell from almost 60 per cent at the end of March to 42 per cent at the end of May.

It is hoped that survival rates will improve further still thanks to the groundbreaking British study on Dexamethasone, with early findings published in June.

The cheap anti-inflammatory drug has been found to reduce the risk of death significantly in Covid-19 patients on ventilation by as much as 35 per cent and patients on oxygen by 20 per cent.

The current study, by professor Tim Cook, consultant in anaesthesia and intensive care medicine at Royal United Hospitals Bath NHS Foundation Trust and colleagues, examined data on 24 studies on ICU death rates concerning more than 10,000 patients.

Across all studies examined, deaths rates among Covid-19 ICU patients stood at 41.6 per cent at the end of May – a fall from 59.5 per cent at the end of March.

Deaths rates did not differ significantly across the continents compared in the study.

The decrease in death rates may be attributable to a number of factors including rapid learning about the disease and ICU admission criteria changing over time, the researchers said.

The authors point out that their study is also more likely to reflect data on patients who spend long spells in intensive care – in the UK one in five ICU stays (20 per cent) were more than 28 days and 9 per cent were more than 42 days.

They conclude: “This systematic review and meta-analysis of ICU outcome in patients with Covid-19 found an in-ICU mortality rate of 41.6 per cent across international studies.

“There were no significant effects of geographical location, but reported ICU mortality fell over time. Optimistically, as the pandemic progresses, we may be coping better with Covid-19.”

Professor Cook, who is also an honorary professor in anaesthesia at the University of Bristol, added: “The important message is that as the pandemic has progressed and various factors combine, survival of patients admitted to ICU has significantly improved.”

PA

Join our commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in